These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15739845)

  • 21. Visual disorders associated with Alzheimer's disease and optometric management.
    Mancil GL
    J Am Optom Assoc; 1994 Jan; 65(1):27-31. PubMed ID: 8132949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of color in the implicit memory performance of healthy older adults and individuals with Alzheimer's disease.
    Lloyd-Jones TJ
    Neuropsychology; 2005 Jan; 19(1):44-53. PubMed ID: 15656762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of perceptual and lexical-semantic errors to the naming impairments in Alzheimer's disease.
    Cormier P; Margison JA; Fisk JD
    Percept Mot Skills; 1991 Aug; 73(1):175-83. PubMed ID: 1945683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Placing Test: preliminary investigations of a quick and simple memory test designed to be sensitive to pre-dementia Alzheimer's disease but not to normal ageing.
    Anderson EJ; de Jager CA; Iversen SD
    J Clin Exp Neuropsychol; 2006 Aug; 28(6):843-58. PubMed ID: 16822728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalent spatial-rotation deficits in normal aging and Alzheimer's disease.
    Flicker C; Ferris SH; Crook T; Reisberg B; Bartus RT
    J Clin Exp Neuropsychol; 1988 Aug; 10(4):387-99. PubMed ID: 3403702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease].
    Serrano C; Allegri RF; Drake M; Butman J; Harris P; Nagle C; Ranalli C
    Rev Neurol; 2001 Oct 1-15; 33(7):624-7. PubMed ID: 11784949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors.
    Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optometric management of patients with Alzheimer's disease.
    Baker DR; Mendez MF; Townsend JC; Ilsen PF; Bright DC
    J Am Optom Assoc; 1997 Aug; 68(8):483-94. PubMed ID: 9279048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
    Tiraboschi P; Salmon DP; Hansen LA; Hofstetter RC; Thal LJ; Corey-Bloom J
    Brain; 2006 Mar; 129(Pt 3):729-35. PubMed ID: 16401618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verbal and visuospatial span in logopenic progressive aphasia and Alzheimer's disease.
    Foxe DG; Irish M; Hodges JR; Piguet O
    J Int Neuropsychol Soc; 2013 Mar; 19(3):247-53. PubMed ID: 23298815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to modulate neural response to increased task demand in mild Alzheimer's disease: fMRI study of visuospatial processing.
    Vannini P; Lehmann C; Dierks T; Jann K; Viitanen M; Wahlund LO; Almkvist O
    Neurobiol Dis; 2008 Sep; 31(3):287-97. PubMed ID: 18619845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization and norms for a Hebrew naming test.
    Kavé G
    Brain Lang; 2005 Feb; 92(2):204-11. PubMed ID: 15629492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Takeda Three Colors Combination Test: an easy and quick screening for Alzheimer's disease.
    Takeda S; Tajime K; Nakagome K
    J Am Geriatr Soc; 2010 Jun; 58(6):1199-200. PubMed ID: 20722856
    [No Abstract]   [Full Text] [Related]  

  • 36. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. rCBF pathology in Alzheimer's disease is associated with slow processing speed.
    Warkentin S; Erikson C; Janciauskiene S
    Neuropsychologia; 2008 Apr; 46(5):1193-200. PubMed ID: 18067929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls.
    Pavlik V; Massman P; Barber R; Doody R
    J Alzheimers Dis; 2013; 34(2):449-56. PubMed ID: 23241558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroop Color-Word Test performance in patients with Alzheimer's disease.
    Fisher LM; Freed DM; Corkin S
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):745-58. PubMed ID: 2258434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Color discrimination performance in patients with Alzheimer's disease.
    Salamone G; Di Lorenzo C; Mosti S; Lupo F; Cravello L; Palmer K; Musicco M; Caltagirone C
    Dement Geriatr Cogn Disord; 2009; 27(6):501-7. PubMed ID: 19451717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.